{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:10:54Z","timestamp":1789085454531,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Municipal Financial Subsidy of Nanshan District Medical Key Discipline Construction"},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFA0915602"],"award-info":[{"award-number":["2023YFA0915602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Natural Science Foundation Project","award":["JCYJ20240813114502004"],"award-info":[{"award-number":["JCYJ20240813114502004"]}]},{"name":"General Projects of the National Natural Science Foundation of China","award":["82273236"],"award-info":[{"award-number":["82273236"]}]},{"name":"Newly introduced discipline leader fund project in Nanshan District of Shenzhen City","award":["NSZD2023020"],"award-info":[{"award-number":["NSZD2023020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13532-y","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:26:04Z","timestamp":1782390364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression levels of SARS-CoV-2 IgM, IgG, and neutralizing antibodies in a Chinese cohort and detection of peptide-specific antibodies in COVID-19 patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Suli","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosha","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"10350","key":"13532_CR1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","volume":"400","author":"AV Ballering","year":"2022","unstructured":"Ballering AV, et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452\u201361.","journal-title":"Lancet"},{"key":"13532_CR2","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.","journal-title":"EClinicalMedicine"},{"key":"13532_CR3","doi-asserted-by":"crossref","unstructured":"Demko ZO. Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection. medRxiv [Preprint]. 2022.","DOI":"10.1101\/2022.08.08.22278543"},{"issue":"3","key":"13532_CR4","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2023","unstructured":"Swank Z, et al. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clin Infect Dis. 2023;76(3):e487\u201390.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"13532_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210\u20136.","journal-title":"Nat Immunol"},{"key":"13532_CR6","unstructured":"Peluso MJ. Evidence of recent Epstein\u2013Barr virus reactivation in individuals experiencing Long COVID. medRxiv [Preprint]. 2022."},{"issue":"4","key":"13532_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh YK, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698\u2013706.","journal-title":"Gut"},{"issue":"3","key":"13532_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","volume":"71","author":"Q Liu","year":"2022","unstructured":"Liu Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71(3):544\u201352.","journal-title":"Gut"},{"key":"13532_CR9","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.jtauto.2021.100100","volume":"4","author":"G Wallukat","year":"2021","unstructured":"Wallukat G, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100.","journal-title":"J Transl Autoimmun"},{"issue":"5","key":"13532_CR10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881\u2013e89520.","journal-title":"Cell"},{"issue":"9","key":"13532_CR11","doi-asserted-by":"publisher","first-page":"e0257016","DOI":"10.1371\/journal.pone.0257016","volume":"16","author":"JM Arthur","year":"2021","unstructured":"Arthur JM, et al. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16(9):e0257016.","journal-title":"PLoS ONE"},{"issue":"1","key":"13532_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12967-022-03346-2","volume":"20","author":"M Haffke","year":"2022","unstructured":"Haffke M, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME\/CFS). J Transl Med. 2022;20(1):138.","journal-title":"J Transl Med"},{"issue":"1","key":"13532_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-022-01579-5","volume":"21","author":"E Pretorius","year":"2022","unstructured":"Pretorius E, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID\/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022;21(1):148.","journal-title":"Cardiovasc Diabetol"},{"issue":"6578","key":"13532_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1126\/science.abm2052","volume":"375","author":"S Spudich","year":"2022","unstructured":"Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267\u20139.","journal-title":"Science"},{"key":"13532_CR15","unstructured":"Klein J. Distinguishing features of Long COVID identified through immune profiling. medRxiv [Preprint]. 2022."},{"issue":"1","key":"13532_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jim-2021-002051","volume":"70","author":"P Glynne","year":"2022","unstructured":"Glynne P, et al. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med. 2022;70(1):61\u20137.","journal-title":"J Investig Med"},{"issue":"7866","key":"13532_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang EY, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283\u20138.","journal-title":"Nature"},{"issue":"7","key":"13532_CR18","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10875-021-01083-7","volume":"41","author":"J Garcia-Abellan","year":"2021","unstructured":"Garcia-Abellan J, et al. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study. J Clin Immunol. 2021;41(7):1490\u2013501.","journal-title":"J Clin Immunol"},{"key":"13532_CR19","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.1016\/j.lanepe.2021.100122","volume":"6","author":"M Augustin","year":"2021","unstructured":"Augustin M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122.","journal-title":"Lancet Reg Health Eur"},{"key":"13532_CR20","doi-asserted-by":"crossref","unstructured":"Talla A. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. bioRxiv. 2022.","DOI":"10.1101\/2021.05.26.442666"},{"key":"13532_CR21","doi-asserted-by":"crossref","unstructured":"Goh D. Persistence of residual SARS-CoV-2 viral antigen and RNA in tissues of patients with long COVID-19. Research Square [Preprint]. 2022. https:\/\/www.researchsquare.com\/article\/rs-1379777\/v1.","DOI":"10.21203\/rs.3.rs-1379777\/v1"},{"issue":"8","key":"13532_CR22","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/S2213-2600(21)00240-X","volume":"9","author":"LJ Ceulemans","year":"2021","unstructured":"Ceulemans LJ, et al. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir Med. 2021;9(8):e78\u20139.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"13532_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","volume":"15","author":"AV Raveendran","year":"2021","unstructured":"Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021;15(3):869\u201375.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"13532_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13256-020-02582-8","volume":"15","author":"B Zamani","year":"2021","unstructured":"Zamani B, Moeini Taba SM, Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J Med Case Rep. 2021;15(1):29.","journal-title":"J Med Case Rep"},{"issue":"10","key":"13532_CR25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/s41423-020-00542-2","volume":"17","author":"B Oliviero","year":"2020","unstructured":"Oliviero B, et al. Expansion of atypical memory B cells is a prominent feature of COVID-19. Cell Mol Immunol. 2020;17(10):1101\u20133.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"13532_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks SA, et al. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity. 2018;49(4):725\u2013e7396.","journal-title":"Immunity"},{"issue":"6","key":"13532_CR27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ana.26350","volume":"91","author":"MJ Peluso","year":"2022","unstructured":"Peluso MJ, et al. SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19. Ann Neurol. 2022;91(6):772\u201381.","journal-title":"Ann Neurol"},{"key":"13532_CR28","doi-asserted-by":"publisher","first-page":"848886","DOI":"10.3389\/fimmu.2022.848886","volume":"13","author":"M Galan","year":"2022","unstructured":"Galan M, et al. Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers. Front Immunol. 2022;13:848886.","journal-title":"Front Immunol"},{"key":"13532_CR29","doi-asserted-by":"publisher","first-page":"754667","DOI":"10.3389\/fmed.2021.754667","volume":"8","author":"B Hohberger","year":"2021","unstructured":"Hohberger B, et al. Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection. Front Med (Lausanne). 2021;8:754667.","journal-title":"Front Med (Lausanne)"},{"key":"13532_CR30","doi-asserted-by":"publisher","first-page":"eabe0367","DOI":"10.1126\/sciimmunol.abe0367","volume":"5","author":"AS Iyer","year":"2020","unstructured":"Iyer AS, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020;5:eabe0367.","journal-title":"Sci Immunol"},{"key":"13532_CR31","doi-asserted-by":"crossref","unstructured":"Najlaa Assaid S, Arich H, Charoute, et al. Kinetics of SARS-CoV-2 IgM and IgG antibodies 3 months after COVID-19 onset in moroccan patients. Am J Trop Med. 2023;108(1):145\u201354.","DOI":"10.4269\/ajtmh.22-0448"},{"key":"13532_CR32","doi-asserted-by":"crossref","unstructured":"Chen F, Zhong Y, Li J, et al. Dynamic changes of SARS-CoV-2 specific IgM and IgG among population vaccinated with COVID-19 vaccine. Epidemiol Infect. 2022;150:e74:1\u20136.","DOI":"10.1017\/S0950268822000632"},{"key":"13532_CR33","doi-asserted-by":"crossref","unstructured":"Bangandzouboukou JL, Zhang YD, Le Q, et al. Human IgM and IgG responses to an inactivated SARS-CoV-2 vaccine. Curr Med Sci. 2021;41(6):1081\u20136.","DOI":"10.1007\/s11596-021-2461-8"},{"issue":"7","key":"13532_CR34","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2215\/CJN.03500321","volume":"16","author":"A Grupper","year":"2021","unstructured":"Grupper A, Sharon N, Finn T, et al. Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis. Clin J Am Soc Nephrol. 2021;16(7):1037\u201342.","journal-title":"Clin J Am Soc Nephrol"},{"key":"13532_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.immuni.2020.08.003","volume":"53","author":"MJ Bunders","year":"2020","unstructured":"Bunders MJ, Altfeld M. Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic interventions. Immunity. 2020;53:487\u201395.","journal-title":"Immunity"},{"issue":"1","key":"13532_CR36","first-page":"88","volume":"18","author":"NOBIN Hage","year":"2023","unstructured":"Hage NOBIN, Jyothinath KOTHAPALLI, Moji JINI, et al. Seroprevalence of IgG and IgM Antibodies against SARS-CoV-2 Infection in Inhabitants of Itanagar Capital Region, Arunachal Pradesh, India.MAEDICA\u2013a. J Clin Med. 2023;18(1):88\u201395.","journal-title":"J Clin Med"},{"issue":"24","key":"13532_CR37","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.1016\/j.cell.2024.09.043","volume":"187","author":"Y Xiang","year":"2024","unstructured":"Xiang Y, Xu J, McGovern BL, Ranzenigo A, Huang W, Sang Z, Shen J, Diaz-Tapia R, Pham ND, Teunissen AJP, Rodriguez ML, Benjamin J, Taylor DJ, van Leent MMT, White KM, Garc\u00eda-Sastre A, Zhang P, Shi Y. Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy. Cell. 2024;187(24):6966\u2013e698023.","journal-title":"Cell"},{"issue":"11","key":"13532_CR38","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1021\/acs.jmedchem.4c00735","volume":"67","author":"AJ Hone","year":"2024","unstructured":"Hone AJ, Santiago U, Harvey PJ, Tekarli B, Gajewiak J, Craik DJ, Camacho CJ, McIntosh JM. Design, Synthesis, and Structure-Activity Relationships of Novel Peptide Derivatives of the Severe Acute Respiratory Syndrome-Coronavirus-2 Spike-Protein that Potently Inhibit Nicotinic Acetylcholine Receptors. J Med Chem. 2024;67(11):9587\u201398.","journal-title":"J Med Chem"},{"issue":"17","key":"13532_CR39","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1080\/07391102.2021.1905555","volume":"40","author":"M He","year":"2022","unstructured":"He M, Wang Y, Huang S, Zhao N, Cheng M, Zhang X. Computational exploration of natural peptides targeting ACE2. J Biomol Struct Dyn. 2022;40(17):8018\u201329.","journal-title":"J Biomol Struct Dyn"},{"issue":"7","key":"13532_CR40","doi-asserted-by":"publisher","first-page":"2100058","DOI":"10.1002\/smtd.202100058","volume":"5","author":"L Li","year":"2021","unstructured":"Li L, Gao M, Li J, Zu S, Wang Y, Chen C, Wan D, Duan J, Aliyari R, Wang J, Zhang J, Jin Y, Huang W, Jin X, Shi M, Wang Y, Qin C-F, Yang H, Cheng G. Methods to Identify Immunogenic Peptides in SARS-CoV-2 Spike and Protective Monoclonal Antibodies in COVID-19 Patients [J]. Small Methods. 2021;5(7):2100058.","journal-title":"Small Methods"},{"key":"13532_CR41","doi-asserted-by":"crossref","unstructured":"Herrscher C, Eymieux S, Gaborit C, Blasco H, Marlet J, Stefic K, Roingeard P, Grammatico-Guillon L, Hourioux C. ELISA-based analysis reveals an anti-SARS-CoV-2 protein immune response profile associated with disease severity [J]. J Clin Med. 2022;11(2).","DOI":"10.3390\/jcm11020405"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13532-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13532-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13532-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:38:26Z","timestamp":1789083506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13532-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13532"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13532-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided informed consent.This research is guided by the ethical principles of the Declaration of Helsinki. Ethical approval for the study was granted by the Research Ethic Committee of Shenzhen Nanshan People\u2019s Hospital(committee\u2019s reference number:EC-20240202-1014).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1638"}}